Polymyalgia Rheumatica Drugs Market Size

Market Size in USD Mn

CAGR13.9%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	13.9%
Market Concentration	Medium
Major Players	Sparrow Pharmaceuticals, Novartis Pharmaceuticals, Roche Chugai, Chugai Pharmaceutical, Genentech Inc. and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Polymyalgia Rheumatica Drugs Market Analysis

The polymyalgia rheumatica drugs market is estimated to be valued at USD 266 Mn in 2024 and is expected to reach USD 662 Mn by 2031, growing at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.

Market growth can be attributed to the increasing geriatric population worldwide who are at a higher risk of developing polymyalgia rheumatica and rising awareness among people about the disease.